BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37704503)

  • 1. Recurrent Gleason Score 6 Prostate Cancer After Radiotherapy or Ablation: Should We Observe Them All? Results from a Large Multicenter Salvage Radical Prostatectomy Consortium.
    Marra G; Calleris G; Conte F; Benfant N; Rajwa P; Ahmed M; Abreu A; Cacciamani G; Smith JA; Joniau S; Rodriguez-Sanchez L; Sanchez-Salas R; Cathcart P; Gill I; Karnes RJ; Tilki D; Shariat SF; Touijer K; Gontero P
    Eur Urol Focus; 2023 Sep; ():. PubMed ID: 37704503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study.
    Marra G; Karnes RJ; Calleris G; Oderda M; Alessio P; Palazzetti A; Battaglia A; Pisano F; Munegato S; Munoz F; Filippini C; Ricardi U; Linares E; Sanchez-Salas R; Goonewardene S; Dasgupta P; Challacombe B; Popert R; Cahill D; Gillatt D; Persad R; Palou J; Joniau S; Smelzo S; Piechaud T; Taille A; Roupret M; Albisinni S; van Velthoven R; Morlacco A; Vidit S; Gandaglia G; Mottrie A; Smith J; Joshi S; Fiscus G; Berger A; Aron M; Abreu A; Gill IS; Van Der Poel H; Tilki D; Murphy D; Lawrentschuk N; Davis J; Gontero P
    Urol Oncol; 2021 May; 39(5):296.e21-296.e29. PubMed ID: 33436329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration.
    Chade DC; Shariat SF; Cronin AM; Savage CJ; Karnes RJ; Blute ML; Briganti A; Montorsi F; van der Poel HG; Van Poppel H; Joniau S; Godoy G; Hurtado-Coll A; Gleave ME; Dall'Oglio M; Srougi M; Scardino PT; Eastham JA
    Eur Urol; 2011 Aug; 60(2):205-10. PubMed ID: 21420229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
    Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
    Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study.
    Clery R; Grande P; Seisen T; Gobert A; Duquesne I; Villers A; Olivier J; Bernhard JC; Robert G; Beauval JB; Prudhomme T; Bruyère F; Lainé-Caroff P; Waltregny D; Guillonneau B; Panarello D; Ruffion A; De Bayser H; de La Taille A; Roupret M
    World J Urol; 2019 Aug; 37(8):1491-1498. PubMed ID: 30790014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topography of Prostate Cancer Recurrence: A Single-centre Analysis of Salvage Radical Prostatectomy Specimens and Implications for Focal Salvage Treatments.
    Marra G; Calleris G; Massari E; Vissio E; Molinaro L; Cassoni P; D'Agate D; Oderda M; Valerio M; Raskin Y; Joniau S; Papotti M; Gontero P
    Eur Urol Open Sci; 2023 Jan; 47():110-118. PubMed ID: 36601045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy.
    Heidenreich A; Richter S; Thüer D; Pfister D
    Eur Urol; 2010 Mar; 57(3):437-43. PubMed ID: 19303197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature.
    Chade DC; Eastham J; Graefen M; Hu JC; Karnes RJ; Klotz L; Montorsi F; van Poppel H; Scardino PT; Shariat SF
    Eur Urol; 2012 May; 61(5):961-71. PubMed ID: 22280856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis.
    Kishan AU; Shaikh T; Wang PC; Reiter RE; Said J; Raghavan G; Nickols NG; Aronson WJ; Sadeghi A; Kamrava M; Demanes DJ; Steinberg ML; Horwitz EM; Kupelian PA; King CR
    Eur Urol; 2017 May; 71(5):766-773. PubMed ID: 27452951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
    Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
    Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance of biopsy and pathologic ISUP grading in salvage radical prostatectomy patients for recurrent prostate cancer.
    Preisser F; Würnschimmel C; Pose RM; Heinze A; Steuber T; Michl U; Salomon G; Mandel P; Graefen M; Tilki D
    Prostate; 2022 Feb; 82(2):254-259. PubMed ID: 34807461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of post-radiotherapy biopsy before salvage radical prostatectomy.
    Meeks JJ; Walker M; Bernstein M; Kent M; Eastham JA
    BJU Int; 2013 Aug; 112(3):308-12. PubMed ID: 23490232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following First-line Nonsurgical Treatment: Validation of the European Association of Urology Criteria in a Large, Multicenter, Contemporary Cohort.
    Calleris G; Marra G; Benfant N; Rajwa P; Ahmed M; Abreu A; Cacciamani G; Ghoreifi A; Ribeiro L; Westhofen T; Tourinho-Barbosa R; Raskin Y; Veerman H; Albisinni S; Smith JA; Rouprêt M; Oderda M; Massari E; Persad R; Van Der Poel H; Joniau S; Sanchez-Salas R; Kretschmer A; Cathcart P; Gill I; Karnes RJ; Tilki D; Shariat SF; Touijer K; Gontero P
    Eur Urol Focus; 2023 Jul; 9(4):645-649. PubMed ID: 36682962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria.
    Mandel P; Steuber T; Ahyai S; Kriegmair M; Schiffmann J; Boehm K; Heinzer H; Michl U; Schlomm T; Haese A; Huland H; Graefen M; Tilki D
    BJU Int; 2016 Jan; 117(1):55-61. PubMed ID: 25711672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Salvage radical prostatectomy for recurrent prostate cancer. Morbidity, oncological and functional results].
    Vidmar R; Marcq G; Flamand V; Fantoni JC; Hénon F; Villers A; Ouzzane A
    Prog Urol; 2017; 27(8-9):458-466. PubMed ID: 28576424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage Radical Prostatectomy for Radio-Recurrent Prostate Cancer: An Updated Systematic Review of Oncologic, Histopathologic and Functional Outcomes and Predictors of Good Response.
    Grubmüller B; Jahrreiss V; Brönimann S; Quhal F; Mori K; Heidenreich A; Briganti A; Tilki D; Shariat SF
    Curr Oncol; 2021 Jul; 28(4):2881-2892. PubMed ID: 34436018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer.
    Gugliemetti G; Sukhu R; Conca Baenas MA; Meeks J; Sjoberg DD; Eastham JA; Scardino PT; Touijer K
    Actas Urol Esp; 2016 Sep; 40(7):434-9. PubMed ID: 27184342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Salvage Radical Prostatectomy for M0 Castration-resistant Recurrent Prostate Cancer: A Reasonable Option in the Era of New Antiandrogen Therapies?
    Marra G; Calleris G; Alessio P; Oderda M; Palou J; Joniau S; Piechaud T; Smelzo S; Morlacco A; Sharma V; Tilki D; Van der Poel H; Veerman H; Karnes RJ; Gontero P
    Eur Urol Focus; 2021 Jul; 7(4):807-811. PubMed ID: 32414618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage Radical Prostatectomy for Recurrent Prostate Cancer After Primary Nonsurgical Treatment: An Updated Systematic Review.
    Marra G; Marquis A; Yanagisawa T; Shariat SF; Touijer K; Gontero P
    Eur Urol Focus; 2023 Mar; 9(2):251-257. PubMed ID: 36822924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer.
    Chesnut GT; Tin AL; Sivaraman A; Takeda T; Lee T; Fainberg J; Benfante N; Sjoberg DD; Vargas HA; Fine SW; Scardino PT; Eastham JA; Coleman JA; Touijer KA; Zelefsky MJ; Ehdaie B
    Urol Oncol; 2021 Aug; 39(8):495.e17-495.e24. PubMed ID: 33583697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.